Search Results 621-630 of 17866 for Coagulation
Adequate coagulation function defined as prothrombin time or international normalized ratio ≤ 1.5 × ULN unless the participant is receiving anticoagulant ...
History of bleeding disorder or predisposing conditions, blood clotting, or clinically significant abnormal results on coagulation profile at Screening, as ...
subjects with liver metastases); Coagulation: INR, PTT ≤1.5 × ULN. Specimens must be collected within 10 days prior to the start of study combination ...
Family history of VTE or of inherited prothrombotic disorder, recurrence/extension of thrombosis while adequately anti-coagulated. The patient is actively ...
Any congenital coagulation disorder. Asplenia (anatomic or functional). History of photosensitivity or active skin disease that, in the opinion of the ...
- History of coagulation disorder. - Has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results ...
Subjects with abnormal coagulation or who require ongoing complete anticoagulation. Bleeding diathesis. Altered anatomy of the upper gastrointestinal tract ...
About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.
Acceptable coagulation parameters including international normalized ratio (INR) <1.5 and partial thromboplastin time (PTT) ≤ institutional ULN in the ...
Adequate bone marrow, hepatic, renal and coagulation function as defined by the following: Absolute neutrophil count ≥1.5 x 10^9/L, Hemoglobin ≥9.0 g/dL ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.